nepidermin

Case Report

Experience With the Use of Perilesional and Intralesional Recombinant Human Epidermal Growth Factor (Nepidermin) in the Treatment of Patients With Chronic Venous Ulcers

01/21/2019

Luis Fernando Giraldo ;

Maria Teresa Cacua Sanchez ;

This study describes the results in the healing of venous ulcers with the perilesional and intralesional use of nepidermin in patients with a class VI venous insufficiency diagnosis.

This study describes the results...

01/21/2019

Vascular Disease Management

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

nepidermin

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products